Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SANA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
26 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
211 filers reported a long position in SANA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $130.6M | 37.4M | 0% |
| Flagship Pioneering, LLC | $87.3M | 25M | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. | $65.4M | 18.8M | New |
| BlackRock, Inc. | $58.2M | 16.7M | +17.1% |
| STATE STREET CORP | $39.1M | 11.2M | +6.3% |
| CANADA PENSION PLAN INVESTMENT BOARD | $35.7M | 10.2M | 0% |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.2M | 8.4M | +12.7% |
| BANK OF AMERICA CORP /DE/ | $20.1M | 5.7M | +95.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $16.3M | 4.7M | +11.9% |
| Marex Group Ltd | $13.9M | 4M | -0.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.